The 2023 TRAVERSE trial — 5,246 men, 14,304 person-years — found no increased prostate cancer risk from TRT. Here's what Arizona men need to know.
Operated by Steel City Men’s Health and Testosterone LLC
© Copyright 2026 Steel City HRT & Weight Loss. All rights reserved.. All rights reserved. Designed by Topline
Steel City HRT & Weight Loss provides medical services only in states where its providers are properly licensed. Telehealth services are available only to patients physically located in states of licensure at the time of the visit.
This website is for informational purposes only and does not constitute medical advice. Individual results vary. No treatment outcomes are guaranteed.
If you are experiencing a medical emergency, call 911 immediately.